Each Beacon Solution is designed specifically to focus on one therapeutic class. Our sector specialist analysts curate preclinical and clinical data to remove ambiguity and create an unrivalled depth of accuracy and analysis.
Beacon analysts work together with the scientific community to identify the most relevant trends in the targeted therapy landscape and provide you with cutting-edge reports to stay ahead in a rapidly evolving environment.
Tailor your package
Covering all Antibody Drug Conjugates (ADCs), Small Molecule Drug Conjugates (SMDCs), Protein Drug Conjugates (PDCs), Immunotoxins and more
Covering all Bi- and Multi-Specific Antibodies, Antibody Fragments, Augmented Antibodies and more
Beacon Cancer Vaccine provides the solution you need to master the prophylactic and therapeutic cancer vaccines field.
Beacon Cell Therapy covers genetically and non-genetically engineered allogeneic and autologous cell-based therapies across all disease indications.
Covering all Immune Checkpoint Combination Trials and Immune Checkpoint Modulators in development across 27 different checkpoint targets
Covering all cytokines and drugs that target a cytokine or its immediate receptor belonging to the Interleukins, Interferons, Colony-stimulating factors, Transforming growth factor β, Tumour necrosis factor and Chemokines families.
Beacon DDR steps into the field to give drug developers the precise detailed view and broader picture of what is truly happening in the DDR field.
From gene-editing technologies, novel delivery systems, and a variety of genetic materials being used – Beacon Gene Therapy steps into the field to give drug developers a precise and detailed view of how the gene therapy landscape looks.
Covering all therapeutics aimed at treating immune-mediated diseases – Beacon Immune Tolerance provides drug developers with detailed views of the expanding immune tolerance landscape.
Covering all pharmaceutical grade microbiome-based therapeutics across all disease indications – Beacon Microbiome provides drug developers with detailed views of the expanding microbiome landscape.
From capturing viral family and strains to understanding any genetic modifications – Beacon Oncolytic Viruses steps into the field to give drug developers the precise detailed view and broader picture of what is truly happening in the Oncolytic Virus field.
Covering Oligonucleotide-based, mRNA-Based, Ribozyme, and gRNA-Mediated Gene Editing therapies, as well as RNA-Targeted Small Molecules – Beacon RNA covers all disease indications and many modalities to provide a detailed landscape of the RNA space.
Beacon TPD provides the solution you need to master the targeted protein degradation field.
Browse Our Database Solutions
Explore what we cover and how they can work to answer your drug development questions or solve a business need.
Download our Brochure
Find out more about how Beacon can assist you in answering your business needs.
Find out what the key trends and changes are with our latest infographics and blogs with data sampled from our monthly modular reports.
Sign up for our free newsletters
Get the latest stories of the week in short excerpts and how Beacon is tracking this news. Weekly and straight to your inbox.
What our customers say
“I look forward to using Beacon. It saves me hours of trawling through false positive results to my searches.”
Head of Competitive Intelligence
Multinational Pharmaceutical Company
“I’ve rarely seen such dedication from a service provider in understanding and responding to our needs.”
Competitive Intelligence Manager
Top 20 Pharma